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Ascertaining fetal Zika virus infection based on
IgM antibody test in endemic settings
We read with interest the article by Pomar et al.1 on
the association between Zika virus and fetopathy in a
French Guianese population. This observational study
raises some issues that we feel should be brought to the
readers’ attention.
First, the authors’ rationale to include a Zika virus
(ZIKV)-specific IgM antibody test as part of the positive
case definition, despite the test’s cross-reactivity with other
Flavivirus infections and immunizations, is not clear. As
described previously2, the levels of anti-ZIKV IgM may
appear elevated as a result of antibody cross-reaction
among viruses of the same family. A false-positive result
could therefore lead to misdiagnosis of an otherwise
normal fetus. The International Society of Ultrasound
in Obstetrics and Gynecology recommends the use of
reverse transcription polymerase chain reaction (RT-PCR)
or consultation with an expert when interpreting ZIKV
IgM positive results3. For example, studies in endemic
populations in Colombia and Brazil did not include
detection of ZIKV IgM antibodies for defining a
positive case and instead used only RT-PCR assays4,5.
Consequently, suggesting that a test for ZIKV IgM
antibody alone is sufficient for diagnosing ZIKV would
affect outcomes of clinical practice in endemic settings.
Second, the authors did not report the results
of karyotype or chromosomal microarray following
amniocentesis. For example, in the data provided for
Case 6 (a twin pregnancy), the mother tested positive
for serum anti-ZIKV IgM/IgG and for serum RT-PCR
ZIKV but ZIKV was not found in fetal tissues. This
raises the question of whether the central nervous system
abnormalities identified in Fetus A could be attributed to
chromosomal or microdeletion abnormalities6. The same
argument could be made for Case 9, a case of non-immune
hydrops fetalis that showed negative ZIKV RT-PCR of
the placenta and fetal tissues. In this scenario, calculating
the vertical transmission rate of ZIKV could provide a
misleading interpretation.
Third, it is unclear whether or not the authors
investigated other maternal comorbidities, such as
pre-eclampsia, obesity and pregestational diabetes; the
authors reported vascular risk as the sole cofactor.
Moreover, the authors did not provide further explanation
of the contribution to the outcomes from these vascular
risk factors.
We acknowledge that the authors implemented changes
to the definition of microcephaly used by the Centers
for Disease Control and Prevention and the World
Health Organization to decrease the number of false
positives3,6,7. Also, we welcome their findings that the
risk of microcephaly did not differ for the ZIKV-exposed
and non-exposed groups. We also agree that detailed
neurosonography is the method of choice for follow-up in
exposed subjects. However, as medical providers, we need
to understand that the accuracy of the available laboratory
tests to identify fetal infection remains low. We can
address this limitation by performing neurosonography,
close postnatal follow-up and clinical examination. Such
strategies should limit the extent of this outbreak and
improve prognosis of the neonatal population.
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